Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial Article

ESI Most Cited Paper Industry Collaboration International Collaboration

cited authors

  • Mosenzon, Ofri; Blicher, Thalia Marie; Rosenlund, Signe; Eriksson, Jan W.; Heller, Simon; Hels, Ole Holm; Pratley, Richard; Sathyapalan, Thozhukat; Desouza, Cyrus; PIONEER 5 Investigators

authors

Publication Date

  • July 1, 2019

webpage

published in

category

start page

  • 515

end page

  • 527

volume

  • 7

issue

  • 7